CAS 301836-43-1 – 4-[4-(2,3-dihydro-1,4-benzodioxi… | In Stock

CAS No.

301836-43-1

MDL No.

MFCD09037526

C₂₃H₁₈N₄O₃

398.40

InChI Key

DPDZHVCKYBCJHW-UHFFFAOYSA-N

Pack Size	Purity	Price	Availability
1 mg	99%	$22	In Stock
5 mg	99%	$26	In Stock
10 mg	98%	$31	In Stock
25 mg	98%	$59	In Stock
50 mg	98%	$86	In Stock
100 mg	98%	$141	In Stock
250 mg	98%	$224	In Stock
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

1 mg

99%

$22

In Stock

5 mg

99%

$26

In Stock

10 mg

98%

$31

In Stock

25 mg

98%

$59

In Stock

50 mg

98%

$86

In Stock

100 mg

98%

$141

In Stock

250 mg

98%

$224

In Stock

Custom synthesis and bulk supply options are available upon request.

Product Information

4-[4-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-(2-pyridinyl)imidazol-2-yl]benzamide is an imidazole derivative.

CAS No.	301836-43-1
Product Name	4-[4-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-pyridin-2-yl-1H-imidazol-2-yl]benzamide

Heavy Atom Count	30	Rotatable Bond Count	4
Atom Stereo Count	0	Bond Stereo Count	0
HBA	5	HBD	2
TPSA	103.120 Å²	Charge	0
Exact Mass	398.13789	Complexity	1217.19
pKa	7.130	XLogP	3.676

4-[4-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-pyridin-2-yl-1H-imidazol-2-yl]benzamide

Pricing & Availability

Product Information

Properties

Documentation

4-[4-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-pyridin-2-yl-1H-imidazol-2-yl]benzamide

Pricing & Availability

Product Information

Properties

Related Articles

A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.

Discovery of N6-phenyl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamine derivatives as novel CK1 inhibitors using common-feature pharmacophore model based virtual screening and hit-to-lead optimization.

Protein kinase CK1α regulates erythrocyte survival.

Oxidative stress induced by glutathione depletion reproduces pathological modifications of TDP-43 linked to TDP-43 proteinopathies.

Documentation